Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991.
about
Surgery versus radiosurgery for patients with a solitary brain metastasis from non-small cell lung cancerSurgery versus radiosurgery for patients with a solitary brain metastasis from non-small cell lung cancerPatients with single brain metastasis from non-small cell lung cancer equally benefit from stereotactic radiosurgery and surgery: a systematic reviewClinical analysis of patients who survived for less than 3 months after brain metastatectomy.Evaluation of results of linac-based radiosurgery for brain metastases from primary lung cancer.Deconvolution of the gene expression profiles of valuable banked blood specimens for studying the prognostic values of altered peripheral immune cell proportions in cancer patientsRadical irradiation of extracranial oligometastases.Patients undergoing surgery of intracranial metastases have different outcomes based on their primary pathology.Identifying better surgical candidates among recursive partitioning analysis class 2 patients who underwent surgery for intracranial metastases.Risk factors for early death after surgery in patients with brain metastases: reevaluation of the indications for and role of surgery.Trends in survival after surgery for breast cancer metastatic to the brain and spinal column in medicare patients: a population-based analysis.Long-term survival in patients with non-small cell lung cancer and synchronous brain metastasis treated with whole-brain radiotherapy and thoracic chemoradiationThe surgical management of lung cancer.Surgical Treatment of Extrapulmonary Oligometastatic Non-small Cell Lung Cancer.Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer.Isolated brain metastasis as a late recurrence of completely resected non-small cell lung cancer.Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases.Survival prognostic factors for patients with synchronous brain oligometastatic non-small-cell lung carcinoma receiving local therapy.Surgical management of posterior fossa metastases.Oligometastatic non-small-cell lung cancer: current treatment strategies.Stereotactic body radiotherapy treatment of extracranial metastases.Prognostic significance of histology after resection of brain metastases and whole brain radiotherapy in non-small cell lung cancer (NSCLC).Approach for oligometastasis in non-small cell lung cancer.Oligometastatic disease at presentation or recurrence for nonsmall cell lung cancer.A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer.Surgical Management of Non-small Cell Lung Cancer with Solitary Hematogenous Metastases.A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis.Resection of brain metastases from colorectal carcinoma in 73 patients.Non-small cell lung cancer with single brain metastasis: the role of surgical treatment.Retrospective study of 229 surgically treated patients with brain metastases: Prognostic factors, outcome and comparison of recursive partitioning analysis and diagnosis-specific graded prognostic assessment.p53, BCL-2 and BAX in non-small cell lung cancer brain metastases: a comparison of real-time RT-PCR, ELISA and immunohistochemical techniques.Stereotactic radiosurgery for patients with nonsmall cell lung carcinoma metastatic to the brain.Surgical treatment of 70 patients with brain metastases from breast carcinoma.Factors associated with survival and recurrence for patients undergoing surgery of cerebellar metastases.Growth rates of metastatic brain tumors in nonsmall cell lung cancer.Brain metastases research 1990-2010: pattern of citation and systematic review of highly cited articles.Surgical approach in the oligometastatic patient.Long-term survival without surgery in NSCLC patients with synchronous brain oligometastasis: systemic chemotherapy revisited.Surgical management of adrenal metastases from lung cancer.[The conceptual oligometastatic non-small cell lung cancer and therapeutic strategies].
P2860
Q24244603-C4FBB3F9-1F7E-4C9E-8819-CF241729441EQ24246946-71DA3FD4-8DF3-4384-8EE6-3AAFB97F4BBBQ26865729-DA81A45B-B63F-4447-946D-1CAB2CEB2B76Q33490637-4E51C43E-F864-476D-850C-6E03B683CD7EQ33751488-B6DC16CF-2B0B-4DE9-8920-39065E675655Q33800793-07F026EB-FFDC-4406-B054-441C4CC2BB59Q34124296-542DFD4D-6567-49D9-ABA7-FE5211882773Q35000133-752E5F60-EA00-43B1-B33F-61640AB8220BQ35001658-8A8220A5-6397-46B8-B28B-51999C02CF71Q35026083-5965C832-F9CF-4EA0-9E8A-55FA3578C04CQ35357042-7C050B9A-9CBA-483D-9579-B30065380029Q35605403-157513FA-0F04-4258-A7C4-5E3E3B8D8A03Q36391408-2069E796-9269-4E72-967B-A48497A68D6EQ36408553-5D5314FF-2EDA-4725-AAF6-02D0D3100676Q36422709-AFC7E1F0-87F9-462E-99D3-6676D56E5C23Q37002744-7BEFDC85-2729-4A53-AF01-2BC0EBCC27B5Q37056891-943F75E5-BB42-4A53-AB62-125EBCF3E59FQ37103374-34794672-3372-4D6B-A687-6AA28A80A68EQ37427400-2807DC6F-779B-4196-9833-5D039F7024A4Q37643566-ABD5F586-2C02-49D0-814B-BF0699A88DC5Q38046079-CE8CF405-2F61-4CA0-B5DC-8CD2519F31E0Q38334960-D459C41D-0660-490C-82FA-F8D0018FC605Q38741086-AC98DDA5-A022-4388-9D03-F56BE4DA5DAEQ39567988-34E012F5-A402-4D5D-B9E9-E37AABB9D2E0Q41645384-7A8E6F49-863B-42B7-A047-A64A97CCBD7BQ42153889-50576F0E-2DAA-4F3F-B58D-6A123C342E37Q43792293-8C2652B0-AC9A-45B5-A81F-6267FEE6E51EQ44783396-BE726C92-25CD-43D6-8FF6-A03FD4347AADQ45128796-8B732DAB-18BA-4A8E-9845-C1E787425D37Q45140192-2497712B-CB5D-4B6A-BA8C-FBA34D28AD46Q48153322-8D10DF58-E66E-4415-851C-4B11609C6626Q48588692-9CA5DDDC-2039-472A-8726-D4730A47D829Q48598959-D4B1E0F8-351A-4B28-8267-6714A5A3C5D4Q48983137-B10C4D86-11A4-4631-B890-11709A8CF758Q49096959-B65D5D94-EB0E-4119-825B-D7E1B38862CBQ51193862-EDE956C1-B6D6-4BF9-949A-CF1CD4F4567DQ52581734-E841A746-491F-4D78-9346-5B199889911EQ52715757-22D2DFCE-80F0-41FF-8153-489E2423822FQ52905642-97244D61-C33C-4A77-86DF-76E9184BBA62Q53271314-B71CB36E-D28A-4F4A-9CFC-580FD09D2AC3
P2860
Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Survival after surgical treatm ...... treated between 1976 and 1991.
@en
Survival after surgical treatm ...... treated between 1976 and 1991.
@nl
type
label
Survival after surgical treatm ...... treated between 1976 and 1991.
@en
Survival after surgical treatm ...... treated between 1976 and 1991.
@nl
prefLabel
Survival after surgical treatm ...... treated between 1976 and 1991.
@en
Survival after surgical treatm ...... treated between 1976 and 1991.
@nl
P2093
P1476
Survival after surgical treatm ...... treated between 1976 and 1991.
@en
P2093
P304
P356
10.3171/JNS.1995.83.4.0605
P407
P577
1995-10-01T00:00:00Z